United States

Analyst Research Report Snapshot


Gilead Sciences, Inc.






06 Jul 2015





Companies referenced:


Available for Immediate Download

Gilead Sciences, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company. Features: - Detailed information on Gilead Sciences, Inc. required for business and competitor intelligence needs - A study of the major internal and external factors affecting Gilead Sciences, Inc. in the form of a SWOT analysis - An in-depth view of the business model of Gilead Sciences, Inc. including a breakdown and examination of key business segments - Intelligence on Gilead Sciences, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Gilead Sciences, Inc., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Gilead Sciences (Gilead or 'the company') is a research-based biopharmaceutical company engaged in developing and marketing therapies for HIV/AIDS, liver diseases, oncology, inflammation and serious cardiovascular and respiratory conditions. The company operates in North America, Europe and Australia. It is headquartered in Foster City, California, and employed about 6,100 people as of January 31, 2014. The company recorded revenues of $11,201.7 million during the financial year ended December 2013 (FY2013), an increase of 15.5% over FY2012. The operating profit of the company was $4,524 million in FY2013, an increase of 12.8% over FY2012. The net profit was $3,074.8 million in FY2013, an increase of 18.6% over FY2012. Reasons to Purchase: - Gain understanding of Gilead Sciences, Inc. and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Gilead Sciences, Inc. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Gilead Sciences, Inc.’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.